EBS Lands CE Mark, $3.9 Million for Deep-Brain Vision Loss Treatment
6/7/2013 8:54:50 AM
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
EBS Technologies lands CE Mark approval and $3.9 million for its Next Wave deep-brain stimulation device for treating impaired vision. EBS Technologies said it won CE Mark approval in the European Union – plus a cool $3.9 million in Series B financing – for its Next Wave deep-brain stimulation device, touting positive clinical data on the way.
The Berlin-based medical device company said it will put much of the cash toward the roll-out of the Next Wave DBS device, which is designed to reverse vision impairment caused by brain injury and stroke.
Help employers find you! Check out all the jobs and post your resume.
comments powered by